GlassScriptPhysician profile
Kimberly A Kuncl
NPI 1508850173
$2,302.44
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $419 · 2021: $382 · 2022: $642 · 2023: $467 · 2024: $21.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $597.28 | 2019-2023 | |
| Astellas Pharma US INC | $210.02 | 2019-2024 | Veozah, Myrbetriq |
| Millicent US INC | $151.99 | 2020-2021 | |
| Pfizer INC. | $151.21 | 2020-2023 | |
| Hologic Sales and Service, LLC | $143.54 | 2020-2023 | Aptima |
| Mayne Pharma Commercial LLC | $128.70 | 2021-2023 | |
| Gynesonics, INC. | $116.04 | 2022 | |
| Duchesnay USA Incorporated | $92.16 | 2019 | |
| Evofem Biosciences, INC. | $76.02 | 2021-2023 | Phexxi |
| Exeltis, USA INC. | $71.97 | 2020-2022 | |
| Daiichi Sankyo INC. | $64.55 | 2019-2023 | Injectafer |
| Shield Therapeutics INC | $55.29 | 2022-2023 | Accrufer |
| Organon LLC | $47.31 | 2022-2023 | Nexplanon |
| Meditrina | $43.87 | 2021-2022 | |
| Dysis Medical, INC. | $42.09 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $32.43 | 2019 | |
| Merck Sharp & Dohme LLC | $27.88 | 2019 | |
| Allergan, INC. | $27.49 | 2019 | |
| Sumitomo Pharma America, INC. | $27.11 | 2023 | Myfembree |
| Lupin INC. | $25.31 | 2019-2020 | |
| Myovant Sciences INC. | $21.33 | 2022 | |
| Coopersurgical, INC. | $19.65 | 2023 | Summit Doppler |
| Boston Scientific Corporation | $17.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.52 | 2020 | |
| Therapeuticsmd, INC. | $17.09 | 2019 | |
| Davol INC. | $17.03 | 2023 | Arista Ah Flexitip |
| Acessa Health INC. | $15.90 | 2022 | |
| Mission Pharmacal Company | $15.66 | 2020 | |
| Optumhealth Care Solutions, LLC | $14.10 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Mylan Pharmaceuticals INC. | $14.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Kuncl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.